Interestingly, the CCR2 inhibitor resulted in a reduction in EF and an increase in infarct size in the control group, but it did not affect the post-MI cardiac function of Mac-TREM2KO mice (Fig. 2M, N and Supplementary Fig. 5H). This evidence concerns the gene CCR2 and myocardial infarction.